Comprehensive Workup for Pulmonary Hypertension
The workup for pulmonary hypertension should include echocardiography as the first-line non-invasive diagnostic test, followed by ventilation/perfusion scanning, pulmonary function tests with DLCO measurement, routine blood tests, and right heart catheterization for definitive diagnosis. 1
Initial Diagnostic Evaluation
First-Line Testing
- Echocardiography: Essential first screening tool to estimate pulmonary arterial pressure and assess right ventricular function 1
- Electrocardiogram: Evaluate for right axis deviation (93% positive predictive value for PH) 2
- Chest radiography: Assess for enlarged pulmonary arteries and right heart chambers
Laboratory Testing
- Routine biochemistry, hematology, and immunology tests 1
- HIV testing (mandatory for all patients) 1
- Thyroid function tests 1
- NT-proBNP/BNP: Elevated levels correlate with disease severity 1, 2
- Autoimmune screening: If ANA positive, check anti-dsDNA, anti-Scl-70, anti-centromere, anti-RNP, anti-SSA, anti-SSB 1
Pulmonary Assessment
- Pulmonary function tests with DLCO: Essential for initial evaluation 1, 3
- Arterial blood gas analysis: Pattern helps differentiate PH subtypes 3
- Six-minute walk test: Assess exercise capacity and disease severity 1
Imaging Studies
Mandatory Imaging
- Ventilation/perfusion lung scan: Required in all patients with unexplained PH to exclude chronic thromboembolic PH (CTEPH) 1
- High-resolution CT scan: Should be considered in all PH patients to identify underlying lung disease 1
Additional Imaging Based on Clinical Suspicion
- Contrast CT pulmonary angiography: Required for patients with suspected CTEPH 1
- Pulmonary angiography: Should be considered in the workup of CTEPH 1
- Abdominal ultrasound: Recommended for screening of portal hypertension 1
Definitive Diagnosis
Right Heart Catheterization
- Mandatory for definitive diagnosis 1, 4
- Confirms PH: mean pulmonary artery pressure ≥25 mmHg at rest 4
- Determines hemodynamic classification:
- Precapillary PH: PAWP ≤15 mmHg
- Postcapillary PH: PAWP >15 mmHg 4
- Assesses pulmonary vascular resistance and cardiac output 4
Diagnostic Algorithm
- Initial suspicion: Based on symptoms (dyspnea, fatigue, syncope) and risk factors
- Echocardiography: If intermediate or high probability of PH, proceed with further testing
- Exclude common causes: Assess for left heart disease and lung disease
- V/Q scan: If normal or shows only subsegmental defects, consider PAH; if multiple segmental defects, suspect CTEPH
- Right heart catheterization: For definitive diagnosis and hemodynamic classification
Important Considerations
- Avoid lung biopsy: Open or thoracoscopic lung biopsy is not recommended in patients with PAH 1
- Comprehensive approach: The diagnostic workup should systematically rule out common causes of PH (groups 2 and 3) before establishing a diagnosis of PAH (group 1) or CTEPH (group 4) 1
- Referral to expert centers: Patients with suspected PH should be referred to specialized centers for complete evaluation 1
- Prognostic assessment: Include WHO functional class, exercise capacity (6MWT), echocardiographic findings (pericardial effusion, TAPSE), and hemodynamic parameters (RAP, cardiac index) 1
By following this systematic approach, clinicians can accurately diagnose pulmonary hypertension, determine its etiology, and assess disease severity to guide appropriate treatment decisions.